Loading clinical trials...
Loading clinical trials...
A Phase 1, Single-Center, Randomized, Open-Label, Bioavailability and Safety Three Period Crossover Multiple-Dose Study Comparing Two Dose Levels of AMZ001 (Diclofenac Sodium Gel 3.06%) and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Subjects
Conditions
Interventions
Diclofenac Sodium Gel
Locations
1
United States
TKL Research
Fair Lawn, New Jersey, United States
Start Date
July 11, 2023
Primary Completion Date
December 27, 2023
Completion Date
December 2, 2024
Last Updated
April 9, 2025
NCT07310264
NCT00090662
NCT06716502
NCT06290258
NCT07483606
NCT06342713
Lead Sponsor
Amzell
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions